Literature DB >> 4131358

Plasma cell leukemia: detailed studies and response to therapy.

M T Shaw, T W Twele, R E Nordquist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4131358     DOI： 10.1002/1097-0142(197403)33:3<619::aid-cncr2820330305>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  Plasma cell leukemia following treatment with radiotherapy and melphalan.

Authors:  N A Buskard; D A Boyes; L Grossman
Journal:  Can Med Assoc J       Date:  1977-10-08       Impact factor: 8.262

2.  Survival of twenty-two months in a patient with primary plasma cell leukaemia treated with melphalan and prednisolone.

Authors:  J D Walker; R S Kaczmarski
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401

3.  Plasma cell leukemia with an unusual karyotype and prolonged survival following oral alkylating agent therapy.

Authors:  P H Wiernik; D Sciortino; E Paietta; P Papenhausen; N Ciobanu; M Roberts
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Plasma cell leukemia with an unusual karyotype and prolonged survival with oral alkylating agent therapy.

Authors:  P H Wiernik; D Sciortino; E Paietta; P Papenhausen; N Ciobanu; M Roberts
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.